Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas (RHEUMATOLOGY, 2008)

(untitled) - Wordsworth, P; Dijkmans, B; van der Heijde, D; Davis, J; Schiff, M; Kivitz, A; Sieper, J; Mease, P; Kupper, H; Wong, R; Grp, A